IGF-1 LR3 1mg
$170.00
IGF-1 LR3 1mgX10vials
This product comes as powder form. It needs to be mixed Bacteriostatic Water
IGF-1 LR3 (insulin-like growth factor-1 long arginine 3) is a synthetic, modified construct of insulin-like growth factor-1. Because IGF-1 LR3 does not bind to IGF-1 binding proteins very well, it remains active up to 120 times longer than standard IGF-1. This results in improved half-life for the peptide and thus increased activity. IGF-1 LR3 enhances cell division and growth, boosts fat metabolism, and increases muscle repair and hypertrophy by inhibiting myostatin. Recent research suggests that IGF-1 LR3 may also be useful in improving lactation among mothers with young offspring.
Related products
Cagrilintide 5mg
This product comes as powder form. It needs to be mixed Bacteriostatic Water .
Ipamorelin 5mg
Ipamorelin 5mgX10vials
This product comes as powder form. It needs to be mixed Bacteriostatic Water .
MOTS-c 10mg
MOTS-c 10mgX10vials
This product comes as powder form. It needs to be mixed Bacteriostatic Water .
Retatrutide 30mg
Retatrutide 30mgX10vials
This product comes as powder form. It needs to be mixed Bacteriostatic Water .
Semaglutide 10mg
Semaglutide is a derivative of the naturally occurring GLP-1, a peptide that has been shown to lower blood sugar levels and enhance insulin secretion. Research shows that Semaglutide may also improve heart, liver, and lung function while helping to slow or prevent the effects of Alzheimer’s disease. Research with Semaglutide has shown it can significantly decrease appetite by delaying gastric emptying and reducing intestinal motility. Glucagon-Like Peptide-1 (GLP-1) Analogs have been shown to stimulate insulin and suppress glucagon secretion in a glucose-dependent manner.
Semaglutide 5mg
Semaglutide is a derivative of the naturally occurring GLP-1, a peptide that has been shown to lower blood sugar levels and enhance insulin secretion. Research shows that Semaglutide may also improve heart, liver, and lung function while helping to slow or prevent the effects of Alzheimer’s disease. Research with Semaglutide has shown it can significantly decrease appetite by delaying gastric emptying and reducing intestinal motility. Glucagon-Like Peptide-1 (GLP-1) Analogs have been shown to stimulate insulin and suppress glucagon secretion in a glucose-dependent manner.
Reviews
There are no reviews yet.